SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019056-17-000090
Filing Date
2017-02-01
Accepted
2017-02-01 17:01:37
Documents
1
Group Members
ABIR THERAPEUTICS LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G protalix_13g.htm SC 13G 70867
  Complete submission text file 0001019056-17-000090.txt   72656
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 17565657
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10 HASHILOACH STREET POB 7090 PETACH TIKVA L3 4917002
Business Address 10 HASHILOACH STREET POB 7090 PETACH TIKVA L3 4917002 1-514-484-4483
Abir Therapeutics Ltd (Filed by) CIK: 0001696884 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G